Related Experiment Video
Updated: Jun 16, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective
Amita Aggarwal1, Taciana A P Fernandes2, Angela Migowa3
1Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Insights
Childhood-onset systemic lupus erythematosus (cSLE) disproportionately affects children globally. This review highlights disparities in care and research access, emphasizing the urgent need for equitable, worldwide rheumatology services.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Global Health Equity
Background:
- Childhood-onset systemic lupus erythematosus (cSLE) is a severe autoimmune condition with poorer outcomes than adult-onset lupus.
- cSLE's global burden is underestimated, with limited data from low-resource settings indicating high morbidity and mortality.
- Existing research predominantly originates from high-income countries, creating significant knowledge gaps.
Purpose of the Study:
- To review global disparities in rheumatology care and research access for cSLE patients.
- To highlight recent cSLE advancements across diverse geographical regions.
- To identify obstacles hindering cSLE clinical care and research globally and propose solutions.
Main Methods:
- Comprehensive literature review of cSLE research and clinical practice globally.
- Analysis of regional data on cSLE prevalence, treatment access, and research output.
- Synthesis of challenges and proposed strategies for improving global cSLE care.
Main Results:
- Significant global disparities exist in access to specialized rheumatology care for cSLE.
- Patients in lower-resourced regions face greater challenges, leading to higher morbidity and mortality rates.
- Recent cSLE research highlights progress but underscores the need for broader, inclusive studies.
Conclusions:
- Equitable and accessible care for cSLE is a critical unmet need worldwide.
- Collaborative, sustained international efforts are essential to improve cSLE patient outcomes.
- Addressing systemic barriers is crucial for advancing cSLE research and clinical management globally.
Purpose Of Review:
Childhood-onset systemic lupus erythematosus (cSLE) is a severe and potentially life-threatening chronic autoimmune disease. cSLE is more aggressive and has poorer outcomes than adult-onset disease. The global burden of cSLE is poorly understood, with most publications on cSLE originating from high-resourced settings. The reports from less resourced settings indicate high morbidity and mortality in these populations.
Recent Findings:
In this article, we review the disparities in global access to rheumatology care and research for patients with cSLE. We highlight recent cSLE advances from all regions of the globe. We describe current obstacles to cSLE clinical care and research in all settings. Finally, we propose a path forward for high quality, equitable and accessible care to individuals with cSLE everywhere. Individuals with cSLE are at risk for morbidity and death, yet patients worldwide face challenges to adequate access to care and research. Sustained, collaborative efforts are needed to create pathways to improve care and outcomes for these patients.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...